Crossmark

A Multicenter, Retrospective Study (RE-ENACT 2) on the Use of Razumab™ (World’s First Biosimilar Ranibizumab) in Wet Age-Related Macular Degeneration

Published Online: 2019-12-27

Published Print: 2020-03

Authors

Sharma, Shashikant https://orcid.org/0000-0001-8273-6270
Khan, Mujtaba

Chaturvedi, Alok

,
License Information

Text and Data Mining valid from 2019-12-27

Version of Record valid from 2019-12-27
More Information

Article History

Received: 14 November 2019

First Online: 27 December 2019

Change Date: 22 December 2021

Change Type: Update

Change Details: The license text was incorrectly structured. The article has been corrected.

Document is current